SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: maceng2 who wrote (1341282)2/7/2022 2:37:18 PM
From: Tenchusatsu  Read Replies (3) of 1572025
 
LL,
The trial should have been repeated at least.
The Phase III trial IS the repeat.

After seeing good results with the Phase I trial, a company will REPEAT it with a Phase II trial, but with a bigger pool of patients.

After seeing good results with the Phase II trial, a company will REPEAT it with a Phase III trial, but with a much bigger pool of patients.

The only amateurs here are those who don't even know how the process works. It's a standard process. It's been applied to pretty much every single other new drug that has been approved, as well as drugs that have been dropped mid-trial.

Show me the Phase I, II, and III trials for HCQ.

Show me the Phase I, II, and III trials for Vitamin D.

Show me the Phase I, II, and III trials for Ivermectin when it comes to treating COVID.

You can't. It's that simple.

Tenchusatsu
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News